Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma

NCT02098109 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Lymphoma, Non-Hodgkin

Interventions

DRUG: XM02 Filgrastim
DRUG: Filgrastim
PROCEDURE: Apheresis
DRUG: Plerixafor
PROCEDURE: Stem Cell Transplant

Sponsor

Washington University School of Medicine